# Theriva Biologics, Inc.: Form 8-K, filed Jul 7, 2026

- Company: [Theriva Biologics, Inc.](/companies/tovx.md) (CIK 894158)
- Form: 8-K
- Filed: 2026-07-07
- Accepted by EDGAR: Jul 7, 2026, 08:10 ET
- Period: 2026-07-07
- Accession: 0001104659-26-080962
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/894158/000110465926080962/tm2619846d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/894158/000110465926080962/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/894158/000110465926080962/tm2619846d1_8k.htm

Filed Jul 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-080962. Last ingested by Listed: Nov 2, 2026, 16:32 ET. No prices; not investment advice.